Oxalic Acid

Oxalic Acid

SCHEMBL7441783

COc1ccc2c(c1)c(CCN)cn2S(=O)(=O)c1cccs1.O=C(O)C(=O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 15/20 0.71
PPARG P37231 4/20 0.55
PPARD Q03181 4/20 0.55
PPARA Q07869 4/20 0.55
HTR1A P08908 1/20 0.52
DRD2 P14416 1/20 0.52
HTR1D P28221 1/20 0.52
HTR1B P28222 1/20 0.52
HTR1E P28566 1/20 0.52
HTR1F P30939 1/20 0.52
HTR7 P34969 1/20 0.52
DRD3 P35462 1/20 0.52
ADRB2 P07550 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3034948 0.88 HTR6 (0.74) HTR6PPARGPPARDPPARAHTR1A
SCHEMBL3037803 0.86 HTR6 (0.74) HTR6PPARGPPARDPPARAHTR1A
SCHEMBL5499079 0.83 HTR6 (1.00) HTR6HTR1ADRD2HTR1DHTR1B
SCHEMBL13368573 0.83 HTR6 (0.75) HTR6PPARGPPARDPPARAHTR1A
SCHEMBL7441788 0.83 HTR6 (0.61) HTR6PPARGPPARDPPARAHTR1A
SCHEMBL5502012 0.80 HTR6 (1.00) HTR6PPARGPPARDPPARAHTR1A
Hydrochloric Acid SCHEMBL7438828 0.79 HTR6 (0.98) HTR6PPARGPPARDPPARAHTR1A
Trifluoroacetic Acid SCHEMBL7586849 0.79 HTR6 (0.49) HTR6PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL7492450 0.77 HTR6 (0.85) HTR6PPARGPPARDPPARAHTR1A
SCHEMBL7447032 0.77 HTR6 (0.72) HTR6PPARGPPARDPPARAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187805-B1 TREATING CONDITION FOR WHICH SELECTIVE AGONISM OR ANTAGONISM OF 5-HT-6 RECEPTORS IS INDICATED BY ADMINISTERING COMPOUNDS SUCH AS N,N-DIMETHYL 2-(1-(BENZENESULPHONYL)-5-METHOXY-1H-INDOL-3-YL)ETHYLAMINE MERCK SHARP & DOHME LTD. (GB) 2001-02-13 US disclosed